Neonatal hypothyroidism and goiter in one infant of each of two sets of twins due to maternal therapy with antithyroid drugs.
D013956:Antithyroid Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003409:Congenital Hypothyroidism; D005260:Female; D006042:Goiter / Q000139:chemically induced / Q000151:congenital*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D007037:Hypothyroidism / Q000139:chemically induced; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced*; D007235:Infant, Premature, Diseases / Q000139:chemically induced; D007457:Iodine Radioisotopes; D008135:Long-Acting Thyroid Stimulator / Q000097:blood; D008297:Male; D008431:Maternal-Fetal Exchange; D008713:Methimazole / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011441:Propylthiouracil / Q000627:therapeutic use; D013960:Thyroid Function Tests; D013963:Thyroid Hormones / Q000627:therapeutic use; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014427:Twins
D013956:Antithyroid Agents; D007457:Iodine Radioisotopes; D013963:Thyroid Hormones; D008713:Methimazole; D011441:Propylthiouracil; D013972:Thyrotropin; D008135:Long-Acting Thyroid Stimulator; D013974:Thyroxine